Bernd Wegener
Chief Executive Officer at DEUTSCHE BIOTECH INNOVATIV AG
Bernd Wegener active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Founder | 01/01/2009 | - |
| Chief Executive Officer | 01/01/2009 | - | |
| Director/Board Member | 01/01/2009 | - | |
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Chairman | 01/08/2019 | - |
| Founder | 01/01/2009 | - | |
| Director/Board Member | - | 01/08/2019 | |
| Chief Executive Officer | 01/01/2009 | 01/08/2019 | |
| ORGANOBALANCE Medical AG | Chief Executive Officer | - | - |
| Founder | - | - | |
| WCG Consulting AG | Chairman | - | - |
Belano Medical AG
 Belano Medical AG BiotechnologyHealth Technology Belano Medical AG is a leading German company in the development and production of innovative active substances for the human microbiome. The private company is based in Hennigsdorf, Germany. The company's focus is on microbiotic active substances and microbiome products. The CEO of the company is Bernd Wegener. | Chief Executive Officer | - | - |
Career history of Bernd Wegener
Former positions of Bernd Wegener
| Companies | Position | Start | End |
|---|---|---|---|
Bundesverband der Pharmazeutischen Industrie eV
 Bundesverband der Pharmazeutischen Industrie eV Pharmaceuticals: MajorHealth Technology Bundesverband der Pharmazeutischen Industrie eV operates as a German pharmaceutical company. The private company is based in Berlin, Germany. The company was founded in 1951. The CEO is Hans-Georg Feldmeier. | Chief Executive Officer | 01/01/2000 | 01/01/2014 |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 01/01/2000 | 01/01/2014 |
B·R·A·H·M·S GmbH
 B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Chairman | - | 01/01/2009 |
| Founder | - | 01/01/2009 | |
| President | - | 01/01/2009 | |
| CO.DON AG | Director/Board Member | 01/12/2017 | - |
| Chairman | 21/09/2011 | 01/12/2017 |
Statistics
International
| Germany | 9 |
| Switzerland | 2 |
Operational
| Chief Executive Officer | 5 |
| Chairman | 4 |
| Founder | 4 |
Sectoral
| Health Technology | 5 |
| Commercial Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Finance |
| CO.DON AG | Health Services |
| Private companies | 7 |
|---|---|
B·R·A·H·M·S GmbH
B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Commercial Services |
Bundesverband der Pharmazeutischen Industrie eV
Bundesverband der Pharmazeutischen Industrie eV Pharmaceuticals: MajorHealth Technology Bundesverband der Pharmazeutischen Industrie eV operates as a German pharmaceutical company. The private company is based in Berlin, Germany. The company was founded in 1951. The CEO is Hans-Georg Feldmeier. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
| ORGANOBALANCE Medical AG | |
| WCG Consulting AG | |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
Belano Medical AG
Belano Medical AG BiotechnologyHealth Technology Belano Medical AG is a leading German company in the development and production of innovative active substances for the human microbiome. The private company is based in Hennigsdorf, Germany. The company's focus is on microbiotic active substances and microbiome products. The CEO of the company is Bernd Wegener. | Health Technology |
- Stock Market
- Insiders
- Bernd Wegener
- Experience
